Inhaled nitric oxide therapy via nasopharyngeal tube in an infant with end-stage pulmonary hypertension

Pediatrics International

Volumn 40, Issue 2, 1998, Pages 155-158

  Kakuya, Fujio ^a   Takase, Masashi ^a   Ishii, Noriyuki ^a   Kajino, Mayumi ^a   Hayashi, Tokitsugi ^a   Miyamoto, Kazutoshi ^a   Muraki, Senichi ^a   Iwamoto, Jun ^a   Okuno, Akimasa ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Nasopharyngeal tube; Nitric oxide; Pulmonary hypertension

Indexed keywords

NITRIC OXIDE;

ARTICLE; CASE REPORT; DRUG SAFETY; HEART FAILURE; HUMAN; HYPOXEMIA; INFANT; INHALATIONAL DRUG ADMINISTRATION; LUNG HYPOPLASIA; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

ADMINISTRATION, INHALATION; HUMANS; HYPERTENSION, PULMONARY; INFANT, NEWBORN; INTUBATION; MALE; NASOPHARYNX; NITRIC OXIDE;

EID: 0031976593     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.1998.tb01902.x     Document Type: Article

References (16)

1. Robert Jd. Polaner DM. Lang P. Zapol WM. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancer 1992;340: 818–19.
2. Kinsella Jp, Neith Sr, Shaffer E., Abman Ah. Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992; 340: 819–20.
3. Hydar A., Malhere T., Mauriat P. et al. Inhaled nitric oxide for postoperative pulmonary hypertension in patients with congenital heart defects. Lancet 1992; 340: 1545.
4. Oriot D., Boussemart T., Berthier M., Bonneau D., Coisne D. Paradoxical effect of inhaled nitric oxide in a newborn with pulmonary hypertension. Lancet 1993; 342: 364–5.
5. Partanen J., Nieminen Ms. Death of a young woman suffering from primary pulmonary hypertension during inhaled nitric oxide therapy. Arch. Intern. Med. 1995; 155: 875–6.
6. Heal Ca, Spencer Sa. Methaemoglobinemia with high-dose nitric oxide administration. Acta Paediatr. 1995; 84: 1318–19.
7. Giacoia Gp. Nitric oxide: an environmental pollutant as a therapeutic agent. J. Okla. State Med. Assoc. 1995; 88: 17–22.
8. Edwards Ad. The pharmacology of inhaled nitric oxide. Arch. Dis. Child. 1995; 72: F127–30.
9. Tibballs J. Clinical applications of gaseous nitric oxide. Anaesth. Intensive Care 1993; 21: 866–71.
10. Mupanemunda Rh, Edwards Ad. Treatment of newborn infants with inhaled nitric oxide. Arch. Dis. Child. 1995; 72: F131–4.
11. Beals Da, Schloo Bl, Vacanti Jp, Reid Lm, Wilson Jm. Pulmonary growth and remodeling in infants with high-risk congenital diaphragmatic hernia. J. Pediatr. Surg. 1992; 27: 997–1002.
12. Reid Lm. Vascular remodeling. In: Fishman Ap (ed). The Pulmonary Circulation: Normal and Abnormal. Philadelphia: University of Pennsylvania Press, 1990; 259–82.
13. Centers for Disease Control. Recommendations for occupational safety and health standards. Morbid. Mortal. Weekly Rep. 1988; 37: S7–21.
14. Van Meurs Kp. Rhine Wd, Benitz We et al. Lobar lung transplantation as a treatment for congenital diaphragmatic hernia. J. Pediatr. Surg. 1994; 29: 1557–60.
15. Snell Gi, Salamonsen Rf, Bergin P., Esmore Ds, Khan S., Williams Tj. Inhaled nitric oxide used as a bridge to heart-lung transplantation in a patient with end-stage pulmonary hypertension. Am. J. Respir. Crit. Care Med. 1995; 151: 1263–6.
16. Rossaint R., Falke Kj, Lopez F., Slama K., Pison U., Zapol Wm. Inhaled nitric oxide for the adult respiratory distress syndrome. N. Engl. J. Med. 1993; 328: 399–405.